Cullins V E, Blumenthal P D, Remsburg R E, Huggins G R
Department of Obstetrics & Gynecology, Francis Scott Key Medical Center, Baltimore, Maryland 21224.
Contraception. 1993 Feb;47(2):193-203. doi: 10.1016/0010-7824(93)90091-k.
Norplant, the five-year subdermal contraceptive system, is the first implantable contraceptive method approved for general use in the United States. We describe the preliminary experiences of 246 U.S. women who accepted Norplant between April, 1991 and September, 1991. Norplant was well accepted among this diverse general population. Intensive counselling about side effects, especially menstrual changes, is crucial for patient satisfaction. Although 48% of acceptors experienced menstrual cycle changes and 70% experienced at least one side effect, phone calls and unscheduled visits for problems were infrequent. Adequate counselling about side effects obviates the need for a routine follow-up visit one month after insertion.
诺普兰，一种可提供五年避孕效果的皮下避孕系统，是美国首个获批可普遍使用的植入式避孕方法。我们描述了1991年4月至1991年9月期间接受诺普兰的246名美国女性的初步经历。在这个多样化的普通人群中，诺普兰很受欢迎。就副作用，尤其是月经变化进行深入咨询对于患者满意度至关重要。虽然48%的接受者经历了月经周期变化，70%的人至少经历了一种副作用，但因问题打来的电话和不定期就诊情况并不常见。就副作用进行充分咨询避免了在植入后一个月进行常规随访的必要。
